[ comparative study comparing low-dose step-up versus step-down in polycystic ovary syndrome resistant to clomiphene]

ABSTRACT

Polycystic ovary syndrome [PCOS] is one of the most common cause of infertility in women. Clomiphene is the first line of treatment, however 20% of patients are resistant to clomiphene. Because of follicular hypersensitivity to gonadotropins in pcod, multiple follicular growth and development occurs which is cause of OHSS and multiple pregnancy. Our aim of this random and clinical study was comparation between step-down and low dose step-up methods for induction ovulation in clomiphene resistant. 60 cases were included 30 women in low-dose step-up group and 30 women in step-down group. In low-dose step-up HMG 75u/d and in step-down HMG 225 u/d was started on 3[rd] days of cycle, monitoring with vaginal sonography was done on 8[th] days of cycle. When follicle with>14mm in diameter was seen HMG dose was continued in low-dose step-up and was decreased in step-down group. When follicle reached to 18mm in diameter, amp HCG 10000 unit was injected and IUI was performed 36 hours later. Number of HMG ampules, number of follicles>14mm on the day of HCG injection and level of serum estradiol was greater in low dose step up protocol than step down protocol [p<0/0001]. Ovulation rate and pregnancy rate was greater in low dose step up group than step down group with significant difference [p<0/0001]. Our study showed that low-dose step-up regimen with HMG is effective for stimulating ovulation and clinical pregnancy but in view of monofollicular growth, the step down method was more effective and safe. In our study multifolliular growth in step-up method was higher than step-down method. We can predict possibility of Ovarian Hyperstimulation Syndrome in highly sensitive PCOS patients